Frontlight ResearchEarly access
Kidney cancer trials in South Korea
22 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 512 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT05536141 · EU 2024-519142-70-00 - Phase 3Taking peopleA Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
- Where
- Seoul
- Age
- 18 years and over
- People
- 758 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07489495 · EU 2024-516993-31-00 - Phase 3Taking peopleA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
- Where
- Hwasun-gun, Seongnam, Seoul, Taejŏn
- Age
- 18 years and over
- People
- 904 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07227402 · EU 2024-517136-21-00 - Phase 1/2Taking peopleStudy of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Where
- Busan, Cheongju-si, Gyeonggi-do, Hwasun, Incheon, Seongnam-si, Seoul, Suwon
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT04198766 - Phase 1/2Taking peopleA Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Where
- Seoul, Suwon
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT03972657 - Phase 3Taking peopleStudy of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Where
- Busan, Daejeon, Goyang, Seongnam, Seoul, Suwon
- Age
- 18 years and over
- People
- 720 worldwide
- Run by
- Arcus Biosciences, Inc.
See details and how to joinNCT07011719 · EU 2024-515023-11-00 - Phase 1/2Taking peopleSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
- Where
- Seoul
- Age
- 18 years to 120 years
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07049926 · EU 2024-516437-12-00 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Seoul
- Age
- 18 years and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - Phase 1/2Taking peopleGI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- Where
- Daejeon, Seoul, Suwon
- Age
- 18 years and over
- People
- 317 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT04977453 - Phase 1/2Taking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - Phase 1/2Taking peopleA Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 102
- Run by
- GI Innovation, Inc.
See details and how to joinNCT07172802 - Phase 1Taking peopleStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- Where
- Seoul
- Age
- 18 years and over
- People
- 248 worldwide
- Run by
- Calico Life Sciences LLC
See details and how to joinNCT04777994 · EU 2023-507568-38-00 - Phase 2Taking peopleAn Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- Where
- Seoul
- Age
- 19 years and over
- People
- 78
- Run by
- Yonsei University
See details and how to joinNCT07469683 - No phaseEnrolling by invitationEvaluation of 'RUS NE' in Robot-Assisted Partial Nephrectomy: Efficacy, Safety, and Stability
- Where
- Seoul
- Age
- 20 years to 80 years
- People
- 80
- Run by
- Hutom Corp
See details and how to joinNCT06945640 - No phaseTaking peopleA Multicenter Study of RUS NE
- Where
- Kwangju, Seoul
- Age
- 19 years to 80 years
- People
- 204
- Run by
- Hutom Corp
See details and how to joinNCT06868186 - Phase 3CompletedA Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- Where
- Goyang-si, Seongnam-si, Seoul
- Age
- 18 years and over
- People
- 413 worldwide
- Run by
- Xynomic Pharmaceuticals, Inc.
See details and how to joinNCT03592472 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Where
- Seoul, Suwon
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- GI Innovation, Inc.
See details and how to joinNCT05824975 - Phase 3Taking peopleSystemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell Carcinoma
- Where
- Seoul
- Age
- 20 years to 80 years
- People
- 88
- Run by
- Samsung Medical Center
See details and how to joinNCT06467097 - Phase 1/2Taking peopleGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
- Where
- Goyang-si, Seoul
- Age
- 18 years and over
- People
- 125
- Run by
- GeneMedicine Co., Ltd.
See details and how to joinNCT06265025 - No phaseTaking peopleThe Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
- Where
- Seoul, Yongin-si
- Age
- 18 years and over
- People
- 40
- Run by
- Yonsei University
See details and how to joinNCT05753839 - No phaseTaking peopleDevelopment of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome
- Where
- Seoul
- Age
- 20 years and over
- People
- 3,000
- Run by
- Yonsei University
See details and how to joinNCT04625556 - No phaseTaking peopleDevelopment of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
- Where
- Seoul
- Age
- 20 years and over
- People
- 3,000
- Run by
- Yonsei University
See details and how to joinNCT04197414